Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Int J Mol Sci ; 22(11)2021 May 23.
Article in English | MEDLINE | ID: mdl-34071130

ABSTRACT

The diagnosis of autoimmune polyglandular syndrome (APS) types 1/2 is difficult due to their rarity and nonspecific clinical manifestations. APS-1 development can be identified with assays for autoantibodies against cytokines, and APS-2 development with organ-specific antibodies. In this study, a microarray-based multiplex assay was proposed for simultaneous detection of both organ-specific (anti-21-OH, anti-GAD-65, anti-IA2, anti-ICA, anti-TG, and anti-TPO) and APS-1-specific (anti-IFN-ω, anti-IFN-α-2a, and anti-IL-22) autoantibodies. Herein, 206 serum samples from adult patients with APS-1, APS-2, isolated autoimmune endocrine pathologies or non-autoimmune endocrine pathologies and from healthy donors were analyzed. The prevalence of autoantibodies differed among the groups of healthy donors and patients with non-, mono- and multi-endocrine diseases. APS-1 patients were characterized by the presence of at least two specific autoantibodies (specificity 99.5%, sensitivity 100%). Furthermore, in 16 of the 18 patients, the APS-1 assay revealed triple positivity for autoantibodies against IFN-ω, IFN-α-2a and IL-22 (specificity 100%, sensitivity 88.9%). No anti-cytokine autoantibodies were found in the group of patients with non-APS-1 polyendocrine autoimmunity. The accuracy of the microarray-based assay compared to ELISA for organ-specific autoantibodies was 88.8-97.6%. This multiplex assay can be part of the strategy for diagnosing and predicting the development of APS.


Subject(s)
Autoantibodies/blood , Polyendocrinopathies, Autoimmune/immunology , Adolescent , Adult , Autoantigens/immunology , Endocrine System Diseases/blood , Endocrine System Diseases/immunology , Female , Humans , Immobilized Proteins/immunology , Interferon Type I/immunology , Interferon alpha-2/immunology , Interleukins/immunology , Male , Microarray Analysis/methods , Middle Aged , Organ Specificity , Polyendocrinopathies, Autoimmune/blood , Polyendocrinopathies, Autoimmune/diagnosis , Sensitivity and Specificity , Young Adult , Interleukin-22
2.
Probl Endokrinol (Mosk) ; 66(4): 9-15, 2020 09 01.
Article in Russian | MEDLINE | ID: mdl-33351354

ABSTRACT

Genes of HLA system (Human Leukocyte Antigen) play an essential role in the normal functioning of the immune system. There are three classes of genes: I, II, and III. The function of HLA molecules class I is to present antigens of peptides from the cytoplasm to T-lymphocytes on the cell surface, and class II - to present antigens of peptides from the extracellular space. In the classical view, the pathological activation of the immune system in patients with a genetic predisposition can result in the development of autoimmune diseases. However, the influence of this system on the development of non-autoimmune diseases, their severity and prognosis, has been recently considered. Besides, HLA molecules provide a presentation of various infectious agents. In this connection, the loci of the main histocompatibility complex can be considered candidates for determining the genetic predisposition to infectious diseases themselves and their course. This review hypothesizes that specific variants of HLA genes may cause the formation of a «cytokine storm¼ in patients with COVID-19. Identification of a group of patients with particular genetic variations that cause violation of immune tolerance and hyperresponse in the setting of viral infection will help to optimize the algorithm for disease prevention and treatment of such patients and, as a result, to reduce the severity of the epidemiological situation.


Subject(s)
Autoimmune Diseases/immunology , COVID-19/genetics , Cytokine Release Syndrome/genetics , HLA Antigens/immunology , Alleles , Autoimmune Diseases/epidemiology , Autoimmune Diseases/genetics , Autoimmune Diseases/virology , COVID-19/epidemiology , COVID-19/immunology , COVID-19/virology , Cytokine Release Syndrome/immunology , Cytokine Release Syndrome/virology , Genetic Predisposition to Disease , HLA Antigens/genetics , Humans , SARS-CoV-2/genetics , SARS-CoV-2/pathogenicity
SELECTION OF CITATIONS
SEARCH DETAIL
...